| Investor Type | Firm |
| Type of Fund | Other |
| Investing | Japan |
The Nikon Corporation Healthcare Business Unit specializes in the application of optical and precision technologies to the life science and medical fields. Their extensive experience in optics, cultivated over approximately 100 years, has positioned them as a key player in the development of high-performance biological microscopes, as well as other instruments and systems integral to biological science and drug discovery.
Nikon's Life Science Solutions provide cutting-edge tools for visualizing and analyzing biological phenomena, supporting advances in research and development.
Additionally, they offer Eye Care Solutions, using Nikon's original technology to contribute to early detection of eye diseases and improvement of patients' quality of life (QOL) with ophthalmic equipment and systems. Their Contract Cell Development and Manufacturing services cater to the growing need for cell and gene therapy, offering a comprehensive range of development and manufacturing services in Japan. Nikon also emphasizes the importance of well-being, aiming to enhance societal well-being through their offerings in the healthcare sector.
This includes initiatives such as providing patient-friendly retinal examination equipment and contributing to the early signs detection and treatment of retina abnormalities. Through awards like the NIKON JOICO AWARD, Nikon encourages the intersection of artistic and academic pursuits using microscope technology, thus fostering a unique blend of scientific innovation and aesthetic appreciation.
Their commitment to healthcare innovation is further exemplified by their continuous exploration of live cell imaging and analysis to improve culturing technology and understand cell states more effectively.

